University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital
Search Site | Find a Doctor
Print this page
FONT SIZE
Home > Doctors > Richard M. Krieg

Richard M. Krieg, M.D.

Radiation cancer specialist

Dr. Richard Krieg is a radiation oncologist and specialist in the treatment of gastrointestinal and lung cancers and intraoperative radiation therapy. He is interested in improving treatments and managing cancers with the use of radiation therapy. Krieg earned a medical degree at New York University and completed a residency in radiation oncology at the University of California, San Francisco. He is a clinical professor of radiation oncology at UCSF.

Conditions & Treatments

Clinics

Center for Colorectal Surgery
2330 Post St., Suite 260
San Francisco, CA 94115-1799
Phone: (415) 885-3606
Fax: (415) 885-7678

Hours: Monday to Friday
8 a.m. – 4:30 p.m.

Radiation Oncology at Mount Zion
1600 Divisadero St., Basement Level
San Francisco, CA 94143-1708
Phone: (415) 353-9807
Fax: (415) 353-9884

Hours: Monday to Friday
7 a.m. – 6 p.m.

Radiation Oncology at Parnassus
505 Parnassus Ave, Room L-75
San Francisco, CA 94143-0226
Phone: (415) 353-8335
Fax: (415) 353-7281

Hours: Monday to Friday
8 a.m. – 4:30 p.m.

More about Richard M. Krieg

Additional Languages

Spanish
Yiddish

Education

New York University 1977

Residencies

UCSF, Radiation Oncology 1981

Selected Research and Publications

  1. Garcia-Aguilar J, Smith DD, Avila K, Bergsland EK, Chu P, Krieg RM. Optimal timing of surgery after chemoradiation for advanced rectal cancer: preliminary results of a multicenter, nonrandomized phase II prospective trial. Ann Surg. 2011 Jul; 254(1):97-102.
  2. Huang K, Haas-Kogan D, Weinberg V, Krieg R. Higher radiation dose with a shorter treatment duration improves outcome for locally advanced carcinoma of anal canal. World J Gastroenterol. 2007 Feb 14; 13(6):895-900.
  3. Hansen EK, Krieg RM, Azar RJ, Jablons DM, Jahan TM, Zaloudek CJ. Unusual thoracic problems in patients with malignancies: case 3. Carcinoid tumor of the thymus. J Clin Oncol. 2005 Apr 20; 23(12):2859-61.
  4. Hsu IC, Pickett B, Shinohara K, Krieg R, Roach M, Phillips T. Normal tissue dosimetric comparison between HDR prostate implant boost and conformal external beam radiotherapy boost: potential for dose escalation. Int J Radiat Oncol Biol Phys. 2000 Mar 1; 46(4):851-8.
  5. Krieg R, Hoffman R. Current management of unusual genitourinary cancers. Part 2: Urethral cancer. Oncology (Williston Park). 1999 Nov; 13(11):1511-7, 1520; discussion 1523-4.
  6. Krieg R, Hoffman R. Current management of unusual genitourinary cancers. Part 1: Penile cancer. Oncology (Williston Park). 1999 Oct; 13(10):1347-52.
  7. Hoffman R, Welton ML, Klencke B, Weinberg V, Krieg R. The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer. Int J Radiat Oncol Biol Phys. 1999 Apr 1; 44(1):127-31.
  8. Le QT, Fu KK, Kroll S, Ryu JK, Quivey JM, Meyler TS, Krieg RM, Phillips TL. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma. Int J Radiat Oncol Biol Phys. 1997 Aug 1; 39(1):115-26.
  9. Tran LN, Krieg RM, Szabo RJ. Combination chemotherapy and radiotherapy for a locally advanced squamous cell carcinoma of the urethra: a case report. J Urol. 1995 Feb; 153(2):422-3.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions by logging on to UCSF Profiles.

Home • Terms of Use • Site Map • Contact Us       © 2002 - 2012 The Regents of The University of California